Photo taken from Agenus/LinkedIn
Jan 27, 2024, 15:39
Agenus joined oncology leaders from across the globe at ASCO GI (GI24)
Agenus recently posted on their LinkedIn page:
“Agenus joined oncology leaders from across the globe at ASCO GI (GI24). We are proud to partner with Pashtoon Kasi from Weill Cornell Medicine who presented data from the NEST-1 trial of neoadjuvant botensilimab plus balstilimab in resectable mismatch repair proficient and deficient colorectal cancer. The findings underscore the potential to help patients in earlier stages of colorectal cancer.
Learn more about the data by reading our press release and visit the publications section of our website to view the poster.”
Source: Agenus/LinkedIn
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Nov 14, 2024, 00:19
Nov 14, 2024, 00:02
Nov 13, 2024, 23:57
Nov 13, 2024, 23:54
Nov 13, 2024, 23:48